Government IntelligenceGovernment Funding
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Food and Drug Administration
Grant Opportunity from Food and Drug Administration. Official source review is required before action.
- Benefit
- Funding amount undisclosed
- Deadline
- Deadline not explicit in public fields
- Audience
- Review readiness depends on official terms
- Objective OIP Score
- 53/100
No active warningsOfficial public sourceGrants.gov